Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,847 public trials 2,102 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Study to Evaluate VORTX Rx (Theresa)

NCT03741088

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Clinica Diagonal Esplugues de Llobregat, Barcelona, Spain
  • Hospital universitario Mutua Terrassa Terrassa, Barcelona, Spain
  • Hospital Universitario Vall d´Hebrón Barcelona, Spain
View Trial Details
Completed

Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer

NCT00704730

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +16 more
Locations
  • University of Alabama at Birmingham, Comprehensive Cancer Center Birmingham, Alabama, United States
  • TGEN Clinical Research Service at Scottsdale Healthcare Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Burbank, California, United States
View all 113 locations
View Trial Details
Completed

A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)

NCT02127710

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Duarte, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site Fort Myers, Florida, United States
View all 23 locations
View Trial Details
Completed

Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT03194373

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details

Related conditions